These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 8924230

  • 1. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH, Kim JH, Rhee CH, Kang YS, Lee JH, Hong SI, Choi KS.
    J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
    [Abstract] [Full Text] [Related]

  • 2. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

  • 3. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 4. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN.
    Ann Neurol; 1994 Nov 01; 36(5):714-21. PubMed ID: 7979217
    [Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS.
    Anticancer Res; 1996 Nov 01; 16(4A):2009-15. PubMed ID: 8712735
    [Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N, Jaafart H, Isa MN, Abdullah JM.
    Neurol Res; 2004 Jan 01; 26(1):88-92. PubMed ID: 14977064
    [Abstract] [Full Text] [Related]

  • 7. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 01; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

  • 8. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 9. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 May 15; 52(10):2987-90. PubMed ID: 1349850
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 Aug 01; 52(15):4277-9. PubMed ID: 1353411
    [Abstract] [Full Text] [Related]

  • 11. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Oncol Rep; 2004 Jan 01; 11(1):207-11. PubMed ID: 14654927
    [Abstract] [Full Text] [Related]

  • 12. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU.
    Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438
    [Abstract] [Full Text] [Related]

  • 13. Molecular genetic evidence for subtypes of oligoastrocytomas.
    Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A.
    J Neuropathol Exp Neurol; 1997 Oct 01; 56(10):1098-104. PubMed ID: 9329453
    [Abstract] [Full Text] [Related]

  • 14. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan 01; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 15. Molecular pathways in the formation of gliomas.
    von Deimling A, Louis DN, Wiestler OD.
    Glia; 1995 Nov 01; 15(3):328-38. PubMed ID: 8586467
    [Abstract] [Full Text] [Related]

  • 16. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994 Nov 01; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 17. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG.
    Cancer Res; 1994 Mar 15; 54(6):1397-401. PubMed ID: 8137236
    [Abstract] [Full Text] [Related]

  • 18. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M.
    Cancer; 1996 Jul 15; 78(2):287-93. PubMed ID: 8674005
    [Abstract] [Full Text] [Related]

  • 19. Alterations of the TP53 gene in human gliomas.
    Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH.
    Cancer Res; 1994 Mar 01; 54(5):1324-30. PubMed ID: 8118823
    [Abstract] [Full Text] [Related]

  • 20. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
    Zainuddin N, Jaafar H, Isa MN, Abdullah JM.
    Med J Malaysia; 2004 Oct 01; 59(4):468-79. PubMed ID: 15779579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.